SlideShare a Scribd company logo
Cardiovascular Risk Evaluation and   Management  B efore  Kidney Transplantation  Christos Argyropoulos MD, PhD April 9 th  2007
Outline of the presentation ,[object Object],[object Object],[object Object],[object Object],[object Object]
Goals of  Non-Transplant  Surgery Perioperative  Cardiac Assessment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Goals of  Renal   Transplant  Surgery Perioperative  Cardiac Assessment ,[object Object],[object Object],[object Object]
Epidemiology ,[object Object],[object Object]
Magnitude of risk of major perioperative cardiac events  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],CMAJ • September 13, 2005; 173 (6)
Frequency of MACE in pts at cardiac risk (non-transplant Sx) CMAJ • September 13, 2005; 173 (6)
Frequency of MACE in pts at cardiac risk (non-transplant Sx) 3.9 % for ALL MACEs  CI (3.3% - 4.6%) 3.1% for AMIs CMAJ • September 13, 2005; 173 (6)
Incidence of Perioperative MACE in Renal Transplantation I ,[object Object],[object Object],[object Object],[object Object],[object Object]
Incidence of Perioperative MACE in Renal Transplantation II ,[object Object],[object Object],[object Object],[object Object],[object Object]
Defining “High – Risk” ,[object Object],[object Object],[object Object],[object Object],[object Object]
Is  “high CAD risk” = “high – perioperative” risk?
Is  “high CAD risk” = “high – perioperative” risk? ,[object Object],[object Object]
“ Textbook” Risk Factors for MACEs in Noncardiac Surgery ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],1. New England J Med 1977: 297: 845. 2. Eur Heart J 1987: 8: 179. 3. Ann Thorac Surg 1986: 41: 42. 4. Amer J Med Sci 1994: 308: 41. 5. Ann Vasc Surg 1995: 9: 155.
A Clinical Scoring System for MACEs in Noncardiac Surgery I ,[object Object],[object Object],[object Object],[object Object],Circulation.  1999;100:1043-1049.
A Clinical Scoring System for MACEs in Noncardiac Surgery IIa ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Circulation.  1999;100:1043-1049.   Statistical Trivia : A K-fold cross-validation rather than the  holdout strategy utilized, would have clarified the role of  DM and CKD in perioperative MACE somewhat better
A Clinical Scoring System for MACEs in Noncardiac Surgery IIb ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Circulation.  1999;100:1043-1049.
A Clinical Scoring System for MACEs in Noncardiac Surgery III Circulation.  1999;100:1043-1049.
Clinical Risk Factors for post-transplantation MACEs : Age ,[object Object],[object Object],[object Object],Reference group: 18-34
Clinical Risk Factors for post-transplantation MACEs : Race ,[object Object],[object Object],Reference group: White patients
Clinical Risk Factors for post-txp MACEs : Primary Renal Dx ,[object Object],[object Object],Reference group: GN   C ystic  K idney  D isease
Clinical Risk Factors for post-transplantation MACEs : CAD ,[object Object],[object Object],Reference group: no CAD
Clinical Risk Factors for post-transplantation MACEs : Other
Clinical Risk Factors for post-transplant MACEs – more Cox PH fun ,[object Object],[object Object],[object Object]
Clinical Risk Factors for post-transplantation MACEs: Summary ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Research about MACEs in Renal Transplant v.s. Non – Transplant Operations ,[object Object],[object Object],[object Object],[object Object],[object Object]
Risk Factors for MACEs in High – Risk Vascular Procedures I ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],JAMA.  2001;285:1865-1873
Risk Factors for MACEs in High – Risk Vascular Procedures IIa JAMA.  2001;285:1865-1873
Risk Factors for MACEs in High – Risk Vascular Procedures IIb JAMA.  2001;285:1865-1873
Risk Factors for MACEs in High – Risk Vascular Procedures IIc JAMA.  2001;285:1865-1873
Risk Factors for MACEs in High – Risk Vascular Procedures IIIa JAMA.  2001;285:1865-1873
Risk Factors for MACEs in High – Risk Vascular Procedures IIIb JAMA.  2001;285:1865-1873
“ Objective” predictors of MACEs in Renal Transplantation ,[object Object],[object Object],[object Object]
Prognostic Value of Myocardial   Perfusion Studies in Patients with End-Stage Renal Disease Assessed for Kidney or Kidney-Pancreas Transplantation: A Meta-Analysis
Prognostic Value of Myocardial   Perfusion Studies in Patients with End-Stage Renal Disease Assessed for Kidney or Kidney-Pancreas Transplantation: A Meta-Analysis
Prognostic Value of Myocardial   Perfusion Studies in Patients with End-Stage Renal Disease Assessed for Kidney or Kidney-Pancreas Transplantation: A Meta-Analysis Did these events occur before, immediately after, a long time after the transplant, or on dialysis, the cath table or a CTICU ? Toss a dice – they never told us
[object Object],[object Object],[object Object],[object Object],Prognostic Value of Myocardial Perfusion   Studies in Patients with End-Stage Renal Disease Assessed for Kidney or Kidney-Pancreas Transplantation: A Meta-Analysis
Prognostic Value of Myocardial Perfusion Imaging in Predicting Outcome After Renal Transplantation DM, known CAD, multiple clinical RFs
Prognostic Value of Myocardial Perfusion Imaging in Predicting Outcome After Renal Transplantation ,[object Object],[object Object],[object Object],[object Object]
Prognostic Value of Myocardial Perfusion Imaging in Predicting Outcome After Renal Transplantation Similar to previous studies, no conclusion could be drawn apropos early perioperative MACEs
Noninvasive assessment of cardiac risk in type I diabetic patients being evaluated for combined pancreas-kidney transplantation using dipyridamole – MIBI perfusion  tomographic scintigraphy ,[object Object],[object Object],[object Object],[object Object]
Clinical, resting echo and dipyridamole stress echocardiography findings for the screening of renal transplant candidates ,[object Object],[object Object],[object Object],[object Object]
Clinical, resting echo and dipyridamole stress echocardiography findings for the screening of renal transplant candidates ,[object Object],[object Object],[object Object]
Coronary Angiography Is the   Best Predictor  of Events in Renal  T ransplant Candidates   Compared With Noninvasive Testing ,[object Object],[object Object],[object Object]
Coronary Angiography Is the   Best Predictor  of Events in Renal  T ransplant Candidates   Compared With Noninvasive Testing ,[object Object],[object Object],[object Object]
Coronary Angiography Is the   Best Predictor  of Events in Renal  T ransplant Candidates   Compared With Noninvasive Testing
Is  Coronary Angiography  a much better p redictor  of Events in Renal  T ransplant Candidates   when c ompared  to   Clinical Risk Stratification  ?
Is  Coronary Angiography  a much better p redictor  of  MACEs   after  Renal  T ransplant ation when c ompared  to   Clinical Risk Stratification  ? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Coronary angiogram answers a different question than the one generally asked in the preop period That’s ok .. We have fallen into this trap before
Routine Coronary Angiography in Diabetic  N ephropathy Patients Before Transplantation ,[object Object],[object Object],[object Object],[object Object],[object Object]
Routine Coronary Angiography in Diabetic  N ephropathy Patients Before Transplantation 6% of predialytic patients required dialysis after they had their coronary angiogram !! SAFETY WARNING !
Pretransplant Cardiac Investigations in the Irish Renal Transplant  P opulation ,[object Object],[object Object],[object Object],[object Object],[object Object]
Validation of an Algorithm for Predicting Cardiac Events in Renal Transplant Candidates (“Portland Score”) ,[object Object],[object Object],[object Object],[object Object]
Validation of an Algorithm for Predicting Cardiac Events in Renal Transplant Candidates (“Portland Score”) ,[object Object],[object Object],[object Object],Which question did this study answer?
Derivation and validation of a disease-specific risk score for cardiac  r isk stratification in chronic kidney disease  (“Brisbane Score”) ,[object Object],[object Object],[object Object]
Derivation and validation of a disease-specific risk score for cardiac  r isk stratification in chronic kidney disease  (“Brisbane Score”) ,[object Object]
Derivation and validation of a disease-specific risk score for cardiac  r isk stratification in chronic kidney disease  (“Brisbane Score”) Derivation Population Validation Population
Derivation and validation of a disease-specific risk score for cardiac  r isk stratification in chronic kidney disease  (“Brisbane Score”) Validation  Population Derivation  Population AUC 0.61 0.80 0.58 0.67 AUC 0.60 0.77 0.64 0.67
Risk stratification of patients with chronic kidney  d isease: Results of screening strategies incorporating   clinical risk scoring and dobutamine   stress  echo ,[object Object],[object Object],[object Object],[object Object]
Risk stratification of patients with chronic kidney  d isease: Results of screening strategies incorporating   clinical risk scoring and dobutamine   stress  echo ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Risk stratification of patients with chronic kidney  d isease: Results of screening strategies incorporating   clinical risk scoring and dobutamine   stress  echo ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Remember CHOICE ?
What about pre-emptive revascularization? ,[object Object],[object Object],[object Object],[object Object],[object Object],Lancet. 1992 Oct 24;340(8826):998-1002.
Is Preoperative Cardiac Evaluation Revascularization Ever Necessary?  ,[object Object],[object Object],Certainly, cardiac complications are the most frequent cause of perioperative and late mortality in the patients with PVD. Despite this fact, coronary revascularization has never been prospectively shown to decrease mortality…”
Coronary-Artery Revascularization before Elective Major Vascular Surgery (CARP) ,[object Object],[object Object],[object Object]
Coronary Angiography for the Study Patients ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Outcomes ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Results: Prior to Vascular Surgery ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Results: After Vascular Surgery
Results: Final Analysis ,[object Object]
What about Left Main Disease? ,[object Object],[object Object],Am J Cardiol.  2008 Oct 1;102(7):809-13 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Translating CARP to Renal Transplantation ,[object Object],[object Object]
Detour: What about revascularization? ,[object Object],[object Object]
Detour: What about revascularization? ,[object Object],[object Object],[object Object]
Devereaux, P.J. et al. CMAJ 2005;173:627-634 Potential triggers of states associated with perioperative elevations in troponin levels, arterial thrombosis and fatal myocardial infarction
What Is Perioperative Myocardial Ischemia? ,[object Object],Mangano DT, Hollenberg M, et al, “Perioperative Myocardial Ischemia in Patients Undergoing Noncardiac Surgery-  I. Incidence and Severity During the 4 Day Perioperative Period,” JACC, Vol. 17, No. 4 (1991), pp. 843-850.
Perioperative Ischemia ,[object Object],[object Object],[object Object],[object Object],[object Object]
Perioperative Ischemia
Why Should We Care About Perioperative Myocardial Ischemia? ,[object Object],[object Object],[object Object]
Effect of Bisoprolol on Perioperative Mortality and Myocardial Infarction in High-Risk Patients Undergoing Vascular Surgery. Poldermans D, Boersma E, et al, “Effect of Bisoprolol on Perioperative Mortality and Myocardial  Infarction in High-Risk Patients Undergoing Vascular Surgery,” NEJM, Vol. 341, No. 24 (1999), pp. 1789-1794.
Let’s call a path consult (for an autopsy)
Let’s call a path consult (for an autopsy)
Let’s call a path consult (for an autopsy)
Let’s call a path consult (for an autopsy)
Autopsy Report Question:  has revascularization been shown to prevent acute coronary events in stable CAD? Answer:  The lesions that rupture are different from the ones that get stented i.e. a full metal jacket strategy is unlikely to work
Where do we go from here? ,[object Object],Renal Transplantation does NOT qualify as such
Where do we go from here? ,[object Object],Captures   the clinical characteristics of the transplant candidate Captures the risk profile of transplant surgery
My personal approach I ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
My personal approach II ,[object Object],[object Object],[object Object],[object Object]
My personal approach III ,[object Object],[object Object],[object Object]
EPILOGUE Cardiovascular Risk Evaluation and   Management  B efore  Kidney Transplantation
Goals of  Renal   Transplant  Surgery Perioperative  Cardiac Assessment ,[object Object],[object Object],[object Object],[object Object]
Deciding About Strategies for PTCRA & Interpreting the Literature ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Pre-transplant Cardiac Risk Assessment (PTCRA) may :  ,[object Object],[object Object],[object Object],[object Object],[object Object]
Is Renal Transplantation a Surgical Therapy for CAD?
Is Renal Transplantation a Surgical Therapy for CAD?  ,[object Object],[object Object]
Time for a new conceptual framework? ,[object Object],[object Object],[object Object]
Time for a new conceptual framework? Think not what a stress test  can’t do  preoperatively, think what you  can do  for the patient perioperatively.
Time for a new conceptual framework? ,[object Object],[object Object],[object Object],[object Object]
Time for a new conceptual framework? ,[object Object],[object Object],[object Object],[object Object],Organ allocation policies will determine who will be “renally” revascularized though
Many thanks go to … ,[object Object],[object Object]
ECG evidence of “high troponin” syndrome or normal variant?

More Related Content

What's hot

Patent Foramen Ovale,practical plan of handling.ppt
Patent Foramen Ovale,practical plan of handling.pptPatent Foramen Ovale,practical plan of handling.ppt
Patent Foramen Ovale,practical plan of handling.ppt
Aliaa Shaban
 
Cancer Associated Thrombosis
Cancer Associated ThrombosisCancer Associated Thrombosis
Cancer Associated Thrombosis
Canadian Cancer Survivor Network
 
Cancer-Associated Thrombosis.From LMWH to DOACs
Cancer-Associated Thrombosis.From LMWH to DOACsCancer-Associated Thrombosis.From LMWH to DOACs
Cancer-Associated Thrombosis.From LMWH to DOACs
magdy elmasry
 
Chemotherapy And Cardiotoxicity
Chemotherapy And CardiotoxicityChemotherapy And Cardiotoxicity
Chemotherapy And Cardiotoxicity
Vishal Vanani
 
Contrast induced-Acute Kidney Injury
Contrast induced-Acute Kidney InjuryContrast induced-Acute Kidney Injury
Contrast induced-Acute Kidney Injury
smujeeb11
 
Contrast Induced Nephropathy
Contrast Induced NephropathyContrast Induced Nephropathy
Contrast Induced Nephropathyvishwanath69
 
Gastrointestinal-Pancreatic NET management
Gastrointestinal-Pancreatic NET managementGastrointestinal-Pancreatic NET management
Gastrointestinal-Pancreatic NET management
Chandan K Das
 
Pregnancy in End Stage Renal Disease Patients - Dr. Gawad
Pregnancy in End Stage Renal Disease Patients - Dr. GawadPregnancy in End Stage Renal Disease Patients - Dr. Gawad
Pregnancy in End Stage Renal Disease Patients - Dr. Gawad
NephroTube - Dr.Gawad
 
Cardiorenal syndrome Chaken 2017
Cardiorenal syndrome Chaken 2017 Cardiorenal syndrome Chaken 2017
Cardiorenal syndrome Chaken 2017
CHAKEN MANIYAN
 
ABO Incompatible Kidney Transplantation, Michael Casey, MD (W-0007)
ABO Incompatible Kidney Transplantation, Michael Casey, MD (W-0007)ABO Incompatible Kidney Transplantation, Michael Casey, MD (W-0007)
ABO Incompatible Kidney Transplantation, Michael Casey, MD (W-0007)
UF Nephrology
 
New aphresis prof ehab wafa
New aphresis prof ehab wafaNew aphresis prof ehab wafa
New aphresis prof ehab wafa
FarragBahbah
 
Management of Advances Hepatocellular Carcinoma
Management of Advances Hepatocellular CarcinomaManagement of Advances Hepatocellular Carcinoma
Management of Advances Hepatocellular Carcinoma
Pratap Tiwari
 
Vascular graft infection do we need antimicrobial grafts
Vascular graft infection do we need antimicrobial graftsVascular graft infection do we need antimicrobial grafts
Vascular graft infection do we need antimicrobial grafts
uvcd
 
Contrast Induced Nephropathy
Contrast Induced NephropathyContrast Induced Nephropathy
Contrast Induced Nephropathy
Aris Tsalouchos
 
ABO incompatible kidney transplantation review
ABO incompatible kidney transplantation reviewABO incompatible kidney transplantation review
ABO incompatible kidney transplantation review
Maarten Naesens
 
Novel Oral Anticoagulants (NOACs) in CKD & Dialysis Patients - How to Use? Wh...
Novel Oral Anticoagulants (NOACs) in CKD & Dialysis Patients - How to Use? Wh...Novel Oral Anticoagulants (NOACs) in CKD & Dialysis Patients - How to Use? Wh...
Novel Oral Anticoagulants (NOACs) in CKD & Dialysis Patients - How to Use? Wh...
NephroTube - Dr.Gawad
 
CONTRAST INDUCED NEPHROPATHY(CI-AKI)
CONTRAST INDUCED NEPHROPATHY(CI-AKI)CONTRAST INDUCED NEPHROPATHY(CI-AKI)
CONTRAST INDUCED NEPHROPATHY(CI-AKI)
Praveen Nagula
 
Nuclear Imaging In Cardiology Cme
Nuclear Imaging In Cardiology CmeNuclear Imaging In Cardiology Cme
Nuclear Imaging In Cardiology Cme
Muhammad Ayub
 
Liver transplantation; notes of DM/DNB/Specialists
Liver transplantation; notes of DM/DNB/SpecialistsLiver transplantation; notes of DM/DNB/Specialists
Liver transplantation; notes of DM/DNB/Specialists
Pratap Tiwari
 
What’s new in prostate cancer part 1, 2021
What’s new in prostate cancer part 1, 2021What’s new in prostate cancer part 1, 2021
What’s new in prostate cancer part 1, 2021
Robert J Miller MD
 

What's hot (20)

Patent Foramen Ovale,practical plan of handling.ppt
Patent Foramen Ovale,practical plan of handling.pptPatent Foramen Ovale,practical plan of handling.ppt
Patent Foramen Ovale,practical plan of handling.ppt
 
Cancer Associated Thrombosis
Cancer Associated ThrombosisCancer Associated Thrombosis
Cancer Associated Thrombosis
 
Cancer-Associated Thrombosis.From LMWH to DOACs
Cancer-Associated Thrombosis.From LMWH to DOACsCancer-Associated Thrombosis.From LMWH to DOACs
Cancer-Associated Thrombosis.From LMWH to DOACs
 
Chemotherapy And Cardiotoxicity
Chemotherapy And CardiotoxicityChemotherapy And Cardiotoxicity
Chemotherapy And Cardiotoxicity
 
Contrast induced-Acute Kidney Injury
Contrast induced-Acute Kidney InjuryContrast induced-Acute Kidney Injury
Contrast induced-Acute Kidney Injury
 
Contrast Induced Nephropathy
Contrast Induced NephropathyContrast Induced Nephropathy
Contrast Induced Nephropathy
 
Gastrointestinal-Pancreatic NET management
Gastrointestinal-Pancreatic NET managementGastrointestinal-Pancreatic NET management
Gastrointestinal-Pancreatic NET management
 
Pregnancy in End Stage Renal Disease Patients - Dr. Gawad
Pregnancy in End Stage Renal Disease Patients - Dr. GawadPregnancy in End Stage Renal Disease Patients - Dr. Gawad
Pregnancy in End Stage Renal Disease Patients - Dr. Gawad
 
Cardiorenal syndrome Chaken 2017
Cardiorenal syndrome Chaken 2017 Cardiorenal syndrome Chaken 2017
Cardiorenal syndrome Chaken 2017
 
ABO Incompatible Kidney Transplantation, Michael Casey, MD (W-0007)
ABO Incompatible Kidney Transplantation, Michael Casey, MD (W-0007)ABO Incompatible Kidney Transplantation, Michael Casey, MD (W-0007)
ABO Incompatible Kidney Transplantation, Michael Casey, MD (W-0007)
 
New aphresis prof ehab wafa
New aphresis prof ehab wafaNew aphresis prof ehab wafa
New aphresis prof ehab wafa
 
Management of Advances Hepatocellular Carcinoma
Management of Advances Hepatocellular CarcinomaManagement of Advances Hepatocellular Carcinoma
Management of Advances Hepatocellular Carcinoma
 
Vascular graft infection do we need antimicrobial grafts
Vascular graft infection do we need antimicrobial graftsVascular graft infection do we need antimicrobial grafts
Vascular graft infection do we need antimicrobial grafts
 
Contrast Induced Nephropathy
Contrast Induced NephropathyContrast Induced Nephropathy
Contrast Induced Nephropathy
 
ABO incompatible kidney transplantation review
ABO incompatible kidney transplantation reviewABO incompatible kidney transplantation review
ABO incompatible kidney transplantation review
 
Novel Oral Anticoagulants (NOACs) in CKD & Dialysis Patients - How to Use? Wh...
Novel Oral Anticoagulants (NOACs) in CKD & Dialysis Patients - How to Use? Wh...Novel Oral Anticoagulants (NOACs) in CKD & Dialysis Patients - How to Use? Wh...
Novel Oral Anticoagulants (NOACs) in CKD & Dialysis Patients - How to Use? Wh...
 
CONTRAST INDUCED NEPHROPATHY(CI-AKI)
CONTRAST INDUCED NEPHROPATHY(CI-AKI)CONTRAST INDUCED NEPHROPATHY(CI-AKI)
CONTRAST INDUCED NEPHROPATHY(CI-AKI)
 
Nuclear Imaging In Cardiology Cme
Nuclear Imaging In Cardiology CmeNuclear Imaging In Cardiology Cme
Nuclear Imaging In Cardiology Cme
 
Liver transplantation; notes of DM/DNB/Specialists
Liver transplantation; notes of DM/DNB/SpecialistsLiver transplantation; notes of DM/DNB/Specialists
Liver transplantation; notes of DM/DNB/Specialists
 
What’s new in prostate cancer part 1, 2021
What’s new in prostate cancer part 1, 2021What’s new in prostate cancer part 1, 2021
What’s new in prostate cancer part 1, 2021
 

Viewers also liked

Overview of preoperative cardiac risk assessment
Overview of preoperative cardiac risk assessmentOverview of preoperative cardiac risk assessment
Overview of preoperative cardiac risk assessment
Terry Shaneyfelt
 
Perioperative cardiovascular evaluation for non cardiac surgery
Perioperative cardiovascular  evaluation for    non  cardiac surgeryPerioperative cardiovascular  evaluation for    non  cardiac surgery
Perioperative cardiovascular evaluation for non cardiac surgery
PROFESSOR DR. MD. TOUFIQUR RAHMAN
 
Pre operative cardiac assessment dr sadany-1
Pre operative cardiac assessment dr sadany-1Pre operative cardiac assessment dr sadany-1
Pre operative cardiac assessment dr sadany-1
Hossam atef
 
Cardio eval
Cardio evalCardio eval
Cardio eval
Rogelio Engada
 
Preanesthetic evaluation
Preanesthetic evaluationPreanesthetic evaluation
Preanesthetic evaluation
King Jayesh
 
Preoperative pulmonary evaluation and management
Preoperative pulmonary evaluation and managementPreoperative pulmonary evaluation and management
Preoperative pulmonary evaluation and management
Santi Silairatana
 
ACUTE RENAL FAILURE
ACUTE RENAL FAILUREACUTE RENAL FAILURE
ACUTE RENAL FAILURE
Unnikrishnan Prathapadas
 
Anaesthesia for renal transplantation
Anaesthesia for renal transplantationAnaesthesia for renal transplantation
Anaesthesia for renal transplantation
Souvik Maitra
 
KIDNEY TRANSPLANTATION SEMINAR PRESENTATION
KIDNEY TRANSPLANTATION SEMINAR PRESENTATIONKIDNEY TRANSPLANTATION SEMINAR PRESENTATION
KIDNEY TRANSPLANTATION SEMINAR PRESENTATION
fareedresidency
 
Renal transplant: anaesthetic implications & considerations
Renal transplant: anaesthetic implications & considerationsRenal transplant: anaesthetic implications & considerations
Renal transplant: anaesthetic implications & considerations
drsandeepbmore
 
pre op evaluation of cardiac pts for non-cardiac surgery
 pre op evaluation of cardiac pts for non-cardiac surgery pre op evaluation of cardiac pts for non-cardiac surgery
pre op evaluation of cardiac pts for non-cardiac surgery
Vkas Subedi
 
Deciphering the 2014 AHA perioperative managment guidlines
Deciphering the 2014 AHA perioperative managment guidlinesDeciphering the 2014 AHA perioperative managment guidlines
Deciphering the 2014 AHA perioperative managment guidlines
Amr Moustafa Kamel
 
preanasthetic evaluation
preanasthetic evaluationpreanasthetic evaluation
preanasthetic evaluation
anaesthesiology-mgmcri
 
updated Preoperative assessment of noncardiac surgeries
updated Preoperative assessment of noncardiac surgeriesupdated Preoperative assessment of noncardiac surgeries
updated Preoperative assessment of noncardiac surgeries
Basem Enany
 
Evaluation of adult kidney transplant candidates
Evaluation of adult kidney transplant candidatesEvaluation of adult kidney transplant candidates
Evaluation of adult kidney transplant candidatesSunil Kumar Prajapati
 
Pre anaesthetic evaluation.pdfx
Pre anaesthetic evaluation.pdfxPre anaesthetic evaluation.pdfx
Pre anaesthetic evaluation.pdfx
RAJESH EAPEN
 
Anesthetic considerations for kidney transplant in an adult
Anesthetic considerations for kidney transplant in an adult Anesthetic considerations for kidney transplant in an adult
Anesthetic considerations for kidney transplant in an adult
Eko indra
 
Non cardaic surgery preoperative cardiac evaluation aha esc guideline 2015
Non cardaic surgery preoperative cardiac evaluation aha esc guideline 2015Non cardaic surgery preoperative cardiac evaluation aha esc guideline 2015
Non cardaic surgery preoperative cardiac evaluation aha esc guideline 2015
rajasekar nagarajan
 
Renal Transplantation Dr. Jorge L. Posada
Renal Transplantation   Dr. Jorge L. PosadaRenal Transplantation   Dr. Jorge L. Posada
Renal Transplantation Dr. Jorge L. PosadaMedicineAndHealthCancer
 

Viewers also liked (20)

Overview of preoperative cardiac risk assessment
Overview of preoperative cardiac risk assessmentOverview of preoperative cardiac risk assessment
Overview of preoperative cardiac risk assessment
 
Perioperative cardiovascular evaluation for non cardiac surgery
Perioperative cardiovascular  evaluation for    non  cardiac surgeryPerioperative cardiovascular  evaluation for    non  cardiac surgery
Perioperative cardiovascular evaluation for non cardiac surgery
 
Pre operative cardiac assessment dr sadany-1
Pre operative cardiac assessment dr sadany-1Pre operative cardiac assessment dr sadany-1
Pre operative cardiac assessment dr sadany-1
 
Cardio eval
Cardio evalCardio eval
Cardio eval
 
Preanesthetic evaluation
Preanesthetic evaluationPreanesthetic evaluation
Preanesthetic evaluation
 
Preoperative pulmonary evaluation and management
Preoperative pulmonary evaluation and managementPreoperative pulmonary evaluation and management
Preoperative pulmonary evaluation and management
 
ACUTE RENAL FAILURE
ACUTE RENAL FAILUREACUTE RENAL FAILURE
ACUTE RENAL FAILURE
 
Anaesthesia for renal transplantation
Anaesthesia for renal transplantationAnaesthesia for renal transplantation
Anaesthesia for renal transplantation
 
KIDNEY TRANSPLANTATION SEMINAR PRESENTATION
KIDNEY TRANSPLANTATION SEMINAR PRESENTATIONKIDNEY TRANSPLANTATION SEMINAR PRESENTATION
KIDNEY TRANSPLANTATION SEMINAR PRESENTATION
 
Koshy
KoshyKoshy
Koshy
 
Renal transplant: anaesthetic implications & considerations
Renal transplant: anaesthetic implications & considerationsRenal transplant: anaesthetic implications & considerations
Renal transplant: anaesthetic implications & considerations
 
pre op evaluation of cardiac pts for non-cardiac surgery
 pre op evaluation of cardiac pts for non-cardiac surgery pre op evaluation of cardiac pts for non-cardiac surgery
pre op evaluation of cardiac pts for non-cardiac surgery
 
Deciphering the 2014 AHA perioperative managment guidlines
Deciphering the 2014 AHA perioperative managment guidlinesDeciphering the 2014 AHA perioperative managment guidlines
Deciphering the 2014 AHA perioperative managment guidlines
 
preanasthetic evaluation
preanasthetic evaluationpreanasthetic evaluation
preanasthetic evaluation
 
updated Preoperative assessment of noncardiac surgeries
updated Preoperative assessment of noncardiac surgeriesupdated Preoperative assessment of noncardiac surgeries
updated Preoperative assessment of noncardiac surgeries
 
Evaluation of adult kidney transplant candidates
Evaluation of adult kidney transplant candidatesEvaluation of adult kidney transplant candidates
Evaluation of adult kidney transplant candidates
 
Pre anaesthetic evaluation.pdfx
Pre anaesthetic evaluation.pdfxPre anaesthetic evaluation.pdfx
Pre anaesthetic evaluation.pdfx
 
Anesthetic considerations for kidney transplant in an adult
Anesthetic considerations for kidney transplant in an adult Anesthetic considerations for kidney transplant in an adult
Anesthetic considerations for kidney transplant in an adult
 
Non cardaic surgery preoperative cardiac evaluation aha esc guideline 2015
Non cardaic surgery preoperative cardiac evaluation aha esc guideline 2015Non cardaic surgery preoperative cardiac evaluation aha esc guideline 2015
Non cardaic surgery preoperative cardiac evaluation aha esc guideline 2015
 
Renal Transplantation Dr. Jorge L. Posada
Renal Transplantation   Dr. Jorge L. PosadaRenal Transplantation   Dr. Jorge L. Posada
Renal Transplantation Dr. Jorge L. Posada
 

Similar to Cardiovascular risk evaluation and management before renal transplantation slideshare

Perioperative myocardial infarction ppt
Perioperative myocardial infarction pptPerioperative myocardial infarction ppt
Perioperative myocardial infarction pptYogasundaram Sasikumar
 
Higher event rate in patients with known CAD despite a normal myocardial perf...
Higher event rate in patients with known CAD despite a normal myocardial perf...Higher event rate in patients with known CAD despite a normal myocardial perf...
Higher event rate in patients with known CAD despite a normal myocardial perf...
Cardiovascular Diagnosis and Therapy (CDT)
 
Clinical Profile of Acute Coronary Syndrome among Young Adults
Clinical Profile of Acute Coronary Syndrome among Young AdultsClinical Profile of Acute Coronary Syndrome among Young Adults
Clinical Profile of Acute Coronary Syndrome among Young Adults
Premier Publishers
 
Carotid revascularization in cad patients
Carotid revascularization in cad patientsCarotid revascularization in cad patients
Carotid revascularization in cad patients
DIPAK PATADE
 
Factors determining outcomes in grown up patients operated
Factors determining outcomes in grown up patients operatedFactors determining outcomes in grown up patients operated
Factors determining outcomes in grown up patients operated
Dr. Murtaza Kamal MD,DNB,DrNB Ped Cardiology
 
Preop cardiovascular evaluation
Preop cardiovascular evaluationPreop cardiovascular evaluation
Preop cardiovascular evaluation
Brijesh Savidhan
 
J clin exp card predictors of ischaemia and outcomes in egyptian patients wit...
J clin exp card predictors of ischaemia and outcomes in egyptian patients wit...J clin exp card predictors of ischaemia and outcomes in egyptian patients wit...
J clin exp card predictors of ischaemia and outcomes in egyptian patients wit...
Alexandria University, Egypt
 
Severeasymtomaticas
SevereasymtomaticasSevereasymtomaticas
Severeasymtomaticas
escts2012
 
Complications of stroke
Complications of strokeComplications of stroke
Complications of stroke
Hans Garcia
 
Cardiac Evaluation Ppt!
Cardiac Evaluation Ppt!Cardiac Evaluation Ppt!
Cardiac Evaluation Ppt!Abhijit Nair
 
BLOOD TRANSFUSIONS ARE ASSOCIATED WITH MORTALITY IN PEDIATRIC PATIENTS WITH S...
BLOOD TRANSFUSIONS ARE ASSOCIATED WITH MORTALITY IN PEDIATRIC PATIENTS WITH S...BLOOD TRANSFUSIONS ARE ASSOCIATED WITH MORTALITY IN PEDIATRIC PATIENTS WITH S...
BLOOD TRANSFUSIONS ARE ASSOCIATED WITH MORTALITY IN PEDIATRIC PATIENTS WITH S...
Texas Children's Hospital
 
HCM SCD.pptx
HCM SCD.pptxHCM SCD.pptx
HCM SCD.pptx
Aatish Rengan
 
Risk scores in nste acs
Risk scores in nste acsRisk scores in nste acs
Risk scores in nste acs
Vijay Yadav
 
PROSPER trial journal club
PROSPER trial journal clubPROSPER trial journal club
PROSPER trial journal club
Govind Madhaw
 
1-s2.0-S0002914913019292-main
1-s2.0-S0002914913019292-main1-s2.0-S0002914913019292-main
1-s2.0-S0002914913019292-mainBrian Vendel
 
preoperative evaluation for residents of anesthesia part 1
preoperative evaluation for residents of anesthesia part 1preoperative evaluation for residents of anesthesia part 1
preoperative evaluation for residents of anesthesia part 1
mansoor masjedi
 
SISTEMA NERVIOSO
SISTEMA NERVIOSOSISTEMA NERVIOSO
SISTEMA NERVIOSOeglimar00
 
Kwon et.al
Kwon et.alKwon et.al
Impact of statins and beta-blocker therapy on mortality after coronary artery...
Impact of statins and beta-blocker therapy on mortality after coronary artery...Impact of statins and beta-blocker therapy on mortality after coronary artery...
Impact of statins and beta-blocker therapy on mortality after coronary artery...
Paul Schoenhagen
 
Impact of statins and beta-blocker therapy on mortality after coronary artery...
Impact of statins and beta-blocker therapy on mortality after coronary artery...Impact of statins and beta-blocker therapy on mortality after coronary artery...
Impact of statins and beta-blocker therapy on mortality after coronary artery...
Paul Schoenhagen
 

Similar to Cardiovascular risk evaluation and management before renal transplantation slideshare (20)

Perioperative myocardial infarction ppt
Perioperative myocardial infarction pptPerioperative myocardial infarction ppt
Perioperative myocardial infarction ppt
 
Higher event rate in patients with known CAD despite a normal myocardial perf...
Higher event rate in patients with known CAD despite a normal myocardial perf...Higher event rate in patients with known CAD despite a normal myocardial perf...
Higher event rate in patients with known CAD despite a normal myocardial perf...
 
Clinical Profile of Acute Coronary Syndrome among Young Adults
Clinical Profile of Acute Coronary Syndrome among Young AdultsClinical Profile of Acute Coronary Syndrome among Young Adults
Clinical Profile of Acute Coronary Syndrome among Young Adults
 
Carotid revascularization in cad patients
Carotid revascularization in cad patientsCarotid revascularization in cad patients
Carotid revascularization in cad patients
 
Factors determining outcomes in grown up patients operated
Factors determining outcomes in grown up patients operatedFactors determining outcomes in grown up patients operated
Factors determining outcomes in grown up patients operated
 
Preop cardiovascular evaluation
Preop cardiovascular evaluationPreop cardiovascular evaluation
Preop cardiovascular evaluation
 
J clin exp card predictors of ischaemia and outcomes in egyptian patients wit...
J clin exp card predictors of ischaemia and outcomes in egyptian patients wit...J clin exp card predictors of ischaemia and outcomes in egyptian patients wit...
J clin exp card predictors of ischaemia and outcomes in egyptian patients wit...
 
Severeasymtomaticas
SevereasymtomaticasSevereasymtomaticas
Severeasymtomaticas
 
Complications of stroke
Complications of strokeComplications of stroke
Complications of stroke
 
Cardiac Evaluation Ppt!
Cardiac Evaluation Ppt!Cardiac Evaluation Ppt!
Cardiac Evaluation Ppt!
 
BLOOD TRANSFUSIONS ARE ASSOCIATED WITH MORTALITY IN PEDIATRIC PATIENTS WITH S...
BLOOD TRANSFUSIONS ARE ASSOCIATED WITH MORTALITY IN PEDIATRIC PATIENTS WITH S...BLOOD TRANSFUSIONS ARE ASSOCIATED WITH MORTALITY IN PEDIATRIC PATIENTS WITH S...
BLOOD TRANSFUSIONS ARE ASSOCIATED WITH MORTALITY IN PEDIATRIC PATIENTS WITH S...
 
HCM SCD.pptx
HCM SCD.pptxHCM SCD.pptx
HCM SCD.pptx
 
Risk scores in nste acs
Risk scores in nste acsRisk scores in nste acs
Risk scores in nste acs
 
PROSPER trial journal club
PROSPER trial journal clubPROSPER trial journal club
PROSPER trial journal club
 
1-s2.0-S0002914913019292-main
1-s2.0-S0002914913019292-main1-s2.0-S0002914913019292-main
1-s2.0-S0002914913019292-main
 
preoperative evaluation for residents of anesthesia part 1
preoperative evaluation for residents of anesthesia part 1preoperative evaluation for residents of anesthesia part 1
preoperative evaluation for residents of anesthesia part 1
 
SISTEMA NERVIOSO
SISTEMA NERVIOSOSISTEMA NERVIOSO
SISTEMA NERVIOSO
 
Kwon et.al
Kwon et.alKwon et.al
Kwon et.al
 
Impact of statins and beta-blocker therapy on mortality after coronary artery...
Impact of statins and beta-blocker therapy on mortality after coronary artery...Impact of statins and beta-blocker therapy on mortality after coronary artery...
Impact of statins and beta-blocker therapy on mortality after coronary artery...
 
Impact of statins and beta-blocker therapy on mortality after coronary artery...
Impact of statins and beta-blocker therapy on mortality after coronary artery...Impact of statins and beta-blocker therapy on mortality after coronary artery...
Impact of statins and beta-blocker therapy on mortality after coronary artery...
 

More from Christos Argyropoulos

Secondary Hyperparathyroidism in Kidney Transplantation
Secondary Hyperparathyroidism in Kidney TransplantationSecondary Hyperparathyroidism in Kidney Transplantation
Secondary Hyperparathyroidism in Kidney Transplantation
Christos Argyropoulos
 
Management of SHPT in dialysis and beyond.pptx
Management of SHPT in dialysis and beyond.pptxManagement of SHPT in dialysis and beyond.pptx
Management of SHPT in dialysis and beyond.pptx
Christos Argyropoulos
 
Kidney Disease In patients living with HIV
Kidney Disease In patients living with HIVKidney Disease In patients living with HIV
Kidney Disease In patients living with HIV
Christos Argyropoulos
 
RNA Biomarkers in Chronic Kidney Disease
RNA Biomarkers in Chronic Kidney DiseaseRNA Biomarkers in Chronic Kidney Disease
RNA Biomarkers in Chronic Kidney Disease
Christos Argyropoulos
 
Cardiometabolic Benefits of Renal Diabetes and Obesity Medications
Cardiometabolic Benefits of Renal Diabetes and Obesity MedicationsCardiometabolic Benefits of Renal Diabetes and Obesity Medications
Cardiometabolic Benefits of Renal Diabetes and Obesity Medications
Christos Argyropoulos
 
Diabetic Kidney Disease 2022 Update
Diabetic Kidney Disease 2022 UpdateDiabetic Kidney Disease 2022 Update
Diabetic Kidney Disease 2022 Update
Christos Argyropoulos
 
Aldosterone in diabetes and other kidney diseases
Aldosterone in diabetes and other kidney diseasesAldosterone in diabetes and other kidney diseases
Aldosterone in diabetes and other kidney diseases
Christos Argyropoulos
 
Survival Analysis With Generalized Additive Models
Survival Analysis With Generalized Additive ModelsSurvival Analysis With Generalized Additive Models
Survival Analysis With Generalized Additive Models
Christos Argyropoulos
 
Diabetic kidney disease 2021
Diabetic kidney disease 2021 Diabetic kidney disease 2021
Diabetic kidney disease 2021
Christos Argyropoulos
 
Diabetic kidney disease 2021 all_slides
Diabetic kidney disease 2021 all_slidesDiabetic kidney disease 2021 all_slides
Diabetic kidney disease 2021 all_slides
Christos Argyropoulos
 
Diabetic kidney disease 2021
Diabetic kidney disease 2021Diabetic kidney disease 2021
Diabetic kidney disease 2021
Christos Argyropoulos
 
Sglt2 across the_spectrum_of_kidney_diseases
Sglt2 across the_spectrum_of_kidney_diseasesSglt2 across the_spectrum_of_kidney_diseases
Sglt2 across the_spectrum_of_kidney_diseases
Christos Argyropoulos
 
Acute Kidney Injury in Patients with Cancer
Acute Kidney Injury in Patients with CancerAcute Kidney Injury in Patients with Cancer
Acute Kidney Injury in Patients with Cancer
Christos Argyropoulos
 
Telenephrology
TelenephrologyTelenephrology
Telenephrology
Christos Argyropoulos
 
Hyperparathyroidism after kidney transplantation
Hyperparathyroidism after kidney transplantationHyperparathyroidism after kidney transplantation
Hyperparathyroidism after kidney transplantation
Christos Argyropoulos
 
ASK1 Inhibition in Diabetic Kidney Disease
ASK1 Inhibition in Diabetic Kidney DiseaseASK1 Inhibition in Diabetic Kidney Disease
ASK1 Inhibition in Diabetic Kidney Disease
Christos Argyropoulos
 
Chronic Kidney Disease Update 2019
Chronic Kidney Disease Update 2019Chronic Kidney Disease Update 2019
Chronic Kidney Disease Update 2019
Christos Argyropoulos
 
Involuntary discharges from the dialysis unit
Involuntary discharges from the dialysis unitInvoluntary discharges from the dialysis unit
Involuntary discharges from the dialysis unit
Christos Argyropoulos
 
Update on diabetic nephropathy 2019
Update on diabetic nephropathy 2019Update on diabetic nephropathy 2019
Update on diabetic nephropathy 2019
Christos Argyropoulos
 
Update on Diabetic Nephropathy (2018)
Update on Diabetic Nephropathy (2018)Update on Diabetic Nephropathy (2018)
Update on Diabetic Nephropathy (2018)
Christos Argyropoulos
 

More from Christos Argyropoulos (20)

Secondary Hyperparathyroidism in Kidney Transplantation
Secondary Hyperparathyroidism in Kidney TransplantationSecondary Hyperparathyroidism in Kidney Transplantation
Secondary Hyperparathyroidism in Kidney Transplantation
 
Management of SHPT in dialysis and beyond.pptx
Management of SHPT in dialysis and beyond.pptxManagement of SHPT in dialysis and beyond.pptx
Management of SHPT in dialysis and beyond.pptx
 
Kidney Disease In patients living with HIV
Kidney Disease In patients living with HIVKidney Disease In patients living with HIV
Kidney Disease In patients living with HIV
 
RNA Biomarkers in Chronic Kidney Disease
RNA Biomarkers in Chronic Kidney DiseaseRNA Biomarkers in Chronic Kidney Disease
RNA Biomarkers in Chronic Kidney Disease
 
Cardiometabolic Benefits of Renal Diabetes and Obesity Medications
Cardiometabolic Benefits of Renal Diabetes and Obesity MedicationsCardiometabolic Benefits of Renal Diabetes and Obesity Medications
Cardiometabolic Benefits of Renal Diabetes and Obesity Medications
 
Diabetic Kidney Disease 2022 Update
Diabetic Kidney Disease 2022 UpdateDiabetic Kidney Disease 2022 Update
Diabetic Kidney Disease 2022 Update
 
Aldosterone in diabetes and other kidney diseases
Aldosterone in diabetes and other kidney diseasesAldosterone in diabetes and other kidney diseases
Aldosterone in diabetes and other kidney diseases
 
Survival Analysis With Generalized Additive Models
Survival Analysis With Generalized Additive ModelsSurvival Analysis With Generalized Additive Models
Survival Analysis With Generalized Additive Models
 
Diabetic kidney disease 2021
Diabetic kidney disease 2021 Diabetic kidney disease 2021
Diabetic kidney disease 2021
 
Diabetic kidney disease 2021 all_slides
Diabetic kidney disease 2021 all_slidesDiabetic kidney disease 2021 all_slides
Diabetic kidney disease 2021 all_slides
 
Diabetic kidney disease 2021
Diabetic kidney disease 2021Diabetic kidney disease 2021
Diabetic kidney disease 2021
 
Sglt2 across the_spectrum_of_kidney_diseases
Sglt2 across the_spectrum_of_kidney_diseasesSglt2 across the_spectrum_of_kidney_diseases
Sglt2 across the_spectrum_of_kidney_diseases
 
Acute Kidney Injury in Patients with Cancer
Acute Kidney Injury in Patients with CancerAcute Kidney Injury in Patients with Cancer
Acute Kidney Injury in Patients with Cancer
 
Telenephrology
TelenephrologyTelenephrology
Telenephrology
 
Hyperparathyroidism after kidney transplantation
Hyperparathyroidism after kidney transplantationHyperparathyroidism after kidney transplantation
Hyperparathyroidism after kidney transplantation
 
ASK1 Inhibition in Diabetic Kidney Disease
ASK1 Inhibition in Diabetic Kidney DiseaseASK1 Inhibition in Diabetic Kidney Disease
ASK1 Inhibition in Diabetic Kidney Disease
 
Chronic Kidney Disease Update 2019
Chronic Kidney Disease Update 2019Chronic Kidney Disease Update 2019
Chronic Kidney Disease Update 2019
 
Involuntary discharges from the dialysis unit
Involuntary discharges from the dialysis unitInvoluntary discharges from the dialysis unit
Involuntary discharges from the dialysis unit
 
Update on diabetic nephropathy 2019
Update on diabetic nephropathy 2019Update on diabetic nephropathy 2019
Update on diabetic nephropathy 2019
 
Update on Diabetic Nephropathy (2018)
Update on Diabetic Nephropathy (2018)Update on Diabetic Nephropathy (2018)
Update on Diabetic Nephropathy (2018)
 

Recently uploaded

Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 

Recently uploaded (20)

Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 

Cardiovascular risk evaluation and management before renal transplantation slideshare

  • 1. Cardiovascular Risk Evaluation and Management B efore Kidney Transplantation Christos Argyropoulos MD, PhD April 9 th 2007
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7. Frequency of MACE in pts at cardiac risk (non-transplant Sx) CMAJ • September 13, 2005; 173 (6)
  • 8. Frequency of MACE in pts at cardiac risk (non-transplant Sx) 3.9 % for ALL MACEs CI (3.3% - 4.6%) 3.1% for AMIs CMAJ • September 13, 2005; 173 (6)
  • 9.
  • 10.
  • 11.
  • 12. Is “high CAD risk” = “high – perioperative” risk?
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18. A Clinical Scoring System for MACEs in Noncardiac Surgery III Circulation. 1999;100:1043-1049.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23. Clinical Risk Factors for post-transplantation MACEs : Other
  • 24.
  • 25.
  • 26.
  • 27.
  • 28. Risk Factors for MACEs in High – Risk Vascular Procedures IIa JAMA.  2001;285:1865-1873
  • 29. Risk Factors for MACEs in High – Risk Vascular Procedures IIb JAMA.  2001;285:1865-1873
  • 30. Risk Factors for MACEs in High – Risk Vascular Procedures IIc JAMA.  2001;285:1865-1873
  • 31. Risk Factors for MACEs in High – Risk Vascular Procedures IIIa JAMA.  2001;285:1865-1873
  • 32. Risk Factors for MACEs in High – Risk Vascular Procedures IIIb JAMA.  2001;285:1865-1873
  • 33.
  • 34. Prognostic Value of Myocardial Perfusion Studies in Patients with End-Stage Renal Disease Assessed for Kidney or Kidney-Pancreas Transplantation: A Meta-Analysis
  • 35. Prognostic Value of Myocardial Perfusion Studies in Patients with End-Stage Renal Disease Assessed for Kidney or Kidney-Pancreas Transplantation: A Meta-Analysis
  • 36. Prognostic Value of Myocardial Perfusion Studies in Patients with End-Stage Renal Disease Assessed for Kidney or Kidney-Pancreas Transplantation: A Meta-Analysis Did these events occur before, immediately after, a long time after the transplant, or on dialysis, the cath table or a CTICU ? Toss a dice – they never told us
  • 37.
  • 38. Prognostic Value of Myocardial Perfusion Imaging in Predicting Outcome After Renal Transplantation DM, known CAD, multiple clinical RFs
  • 39.
  • 40. Prognostic Value of Myocardial Perfusion Imaging in Predicting Outcome After Renal Transplantation Similar to previous studies, no conclusion could be drawn apropos early perioperative MACEs
  • 41.
  • 42.
  • 43.
  • 44.
  • 45.
  • 46. Coronary Angiography Is the Best Predictor of Events in Renal T ransplant Candidates Compared With Noninvasive Testing
  • 47. Is Coronary Angiography a much better p redictor of Events in Renal T ransplant Candidates when c ompared to Clinical Risk Stratification ?
  • 48.
  • 49.
  • 50. Routine Coronary Angiography in Diabetic N ephropathy Patients Before Transplantation 6% of predialytic patients required dialysis after they had their coronary angiogram !! SAFETY WARNING !
  • 51.
  • 52.
  • 53.
  • 54.
  • 55.
  • 56. Derivation and validation of a disease-specific risk score for cardiac r isk stratification in chronic kidney disease (“Brisbane Score”) Derivation Population Validation Population
  • 57. Derivation and validation of a disease-specific risk score for cardiac r isk stratification in chronic kidney disease (“Brisbane Score”) Validation Population Derivation Population AUC 0.61 0.80 0.58 0.67 AUC 0.60 0.77 0.64 0.67
  • 58.
  • 59.
  • 60.
  • 61.
  • 62.
  • 63.
  • 64.
  • 65.
  • 66.
  • 68.
  • 69.
  • 70.
  • 71.
  • 72.
  • 73. Devereaux, P.J. et al. CMAJ 2005;173:627-634 Potential triggers of states associated with perioperative elevations in troponin levels, arterial thrombosis and fatal myocardial infarction
  • 74.
  • 75.
  • 77.
  • 78. Effect of Bisoprolol on Perioperative Mortality and Myocardial Infarction in High-Risk Patients Undergoing Vascular Surgery. Poldermans D, Boersma E, et al, “Effect of Bisoprolol on Perioperative Mortality and Myocardial Infarction in High-Risk Patients Undergoing Vascular Surgery,” NEJM, Vol. 341, No. 24 (1999), pp. 1789-1794.
  • 79. Let’s call a path consult (for an autopsy)
  • 80. Let’s call a path consult (for an autopsy)
  • 81. Let’s call a path consult (for an autopsy)
  • 82. Let’s call a path consult (for an autopsy)
  • 83. Autopsy Report Question: has revascularization been shown to prevent acute coronary events in stable CAD? Answer: The lesions that rupture are different from the ones that get stented i.e. a full metal jacket strategy is unlikely to work
  • 84.
  • 85.
  • 86.
  • 87.
  • 88.
  • 89. EPILOGUE Cardiovascular Risk Evaluation and Management B efore Kidney Transplantation
  • 90.
  • 91.
  • 92.
  • 93. Is Renal Transplantation a Surgical Therapy for CAD?
  • 94.
  • 95.
  • 96. Time for a new conceptual framework? Think not what a stress test can’t do preoperatively, think what you can do for the patient perioperatively.
  • 97.
  • 98.
  • 99.
  • 100. ECG evidence of “high troponin” syndrome or normal variant?

Editor's Notes

  1. Standard Care: 9/53 (17%) died of cardiac causes in perioperative period and 9/53 (17%) had non-fatal MI. Bisoprolol Group: 2/59 (3.3%) died of cardiac causes in perioperative period and 0/59 (0%) had non-fatal MI. Bisoprolol Group including Data from the 8 excluded: 4/67 (6.0%) died of cardiac causes in perioperative period and 1/67 (1.5%) had non-fatal MI.